Literature DB >> 12785812

Copper(I) and copper(II) complexes possessing cross-linked imidazole-phenol ligands: structures and dioxygen reactivity.

Kaliappan Kamaraj1, Eunsuk Kim, Benedikt Galliker, Lev N Zakharov, Arnold L Rheingold, Andreas D Zuberbühler, Kenneth D Karlin.   

Abstract

Catalytic reduction of O2 to H2O, and coupling to membrane proton translocation, occurs at the heterobinuclear heme a3-CuB active site of cytochrome c oxidase. One of the CuB ligated histidines is cross-linked to a neighboring tyrosine (C-N bond; tyrosine C6 and histidine epsilon-nitrogen), and the protic residue of this cross-linked His-Tyr moiety is proposed to participate as both an electron and a proton donor in the catalytic dioxygen reduction event. To provide insight into the chemistry of such a moiety, we have synthesized and characterized tetra- and tridentate pyridylalkylamine chelate ligands {LN4OR and LN3OR (R = H or Me)}, which include an imidazole-phenol (or anisole) cross-link and their copper(I/II) complexes. [CuI(LN4OH)]B(C6F5)4 (1) reacts with dioxygen at -80 degrees C in THF, forming an unstable trans-mu-1,2-peroxodicopper(II)complex, which subsequently converts to a dimeric copper(II)-phenolate complex [{Cu(LN4O-)}2](B(C6F5)4)2 (5a). The close analogue [CuI(LN4OMe)]B(C6F5)4 (3) binds dioxygen reversibly at -80 degrees C in tetrahydrofuran. Stopped-flow kinetics of the reaction [CuI(LN3OH)]ClO4 (2) with O2 in CH2Cl2 indicate a steady formation of the purple dimeric product [{Cu(LN3O-)}2](ClO4)2 (5b), which has been analyzed in the temperature range from -40 to +20 degrees C, DeltaH = -9.6 (6) kJ mol-1, DeltaS = -168 (2) J mol-1 K-1 (k(-40 degrees C) = 1.05(4) x 106 and k(+20 degrees C) = 4.6(2) x 105 M-2 s-1). The X-ray crystal structures of 1, [CuII(LN3OH)(MeOH)(OClO3-)](ClO4) (4), 5a, and 5b are reported.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12785812     DOI: 10.1021/ja034263f

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  7 in total

1.  Isocyanide or nitrosyl complexation to hemes with varying tethered axial base ligand donors: synthesis and characterization.

Authors:  Savita K Sharma; Hyun Kim; Patrick J Rogler; Maxime A Siegler; Kenneth D Karlin
Journal:  J Biol Inorg Chem       Date:  2016-06-27       Impact factor: 3.358

Review 2.  Current advances in the synthesis and biological potencies of tri- and tetra-substituted 1H-imidazoles.

Authors:  Majid M Heravi; Mansoureh Daraie; Vahideh Zadsirjan
Journal:  Mol Divers       Date:  2015-04-12       Impact factor: 2.943

3.  The three-spin intermediate at the O-O cleavage and proton-pumping junction in heme-Cu oxidases.

Authors:  Anex Jose; Andrew W Schaefer; Antonio C Roveda; Wesley J Transue; Sylvia K Choi; Ziqiao Ding; Robert B Gennis; Edward I Solomon
Journal:  Science       Date:  2021-09-09       Impact factor: 63.714

4.  Facile synthesis of optically active imidazole derivatives.

Authors:  Ales Marek; Jiri Kulhanek; Miroslav Ludwig; Filip Bures
Journal:  Molecules       Date:  2007-05-30       Impact factor: 4.411

5.  Could the tyrosine-histidine ligand to CuB in cytochrome c oxidase be coordinatively labile? Implications from a quantum chemical model study of histidine substitutional lability and the effects of the covalent tyrosine-histidine cross-link.

Authors:  Stephen B Colbran; Michael N Paddon-Row
Journal:  J Biol Inorg Chem       Date:  2003-10-15       Impact factor: 3.358

6.  A spectroscopic investigation of a tridentate Cu-complex mimicking the tyrosine-histidine cross-link of cytochrome C oxidase.

Authors:  Adam Offenbacher; Kimberly N White; Indranil Sen; Allen G Oliver; Joseph P Konopelski; Bridgette A Barry; Olöf Einarsdóttir
Journal:  J Phys Chem B       Date:  2009-05-21       Impact factor: 2.991

7.  pH-Potentiometric Investigation towards Chelating Tendencies of p-Hydroquinone and Phenol Iminodiacetate Copper(II) Complexes.

Authors:  Marios Stylianou; Anastasios D Keramidas; Chryssoula Drouza
Journal:  Bioinorg Chem Appl       Date:  2010-06-08       Impact factor: 7.778

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.